API’s and Food Ingredients

Ginkgo Biloba

Products

GINKGO BILOBA EPG 246
Refined and quantified dry extract
Between 22.0% and 27.0% ginkgo flavon glycosides
Between 2.6% to 3.2% bilobalide
Between 2.8% to 3.4% ginkgolides A, B and C

GINKGO BILOBA ETHANOL
Herbal extract
NLT 24% ginkgo flavon glycosides
NLT 6.0% terpene lactones

Pharma use

Anti-dementia
Circulation

Dietary use

Memory loss and concentration disorders
Minor circulatory disorders

Info

Plant
Ginkgo biloba L.

Part of the plant used
Leaves

Description
Light brown, amorphous powder

Cas number
90045-36-6

More to know
Rich in ingredients with outstanding therapeutic value.

A highly purified API, with a very high reproducibility profile.

Steady terpene and glycoside ratio.

Complies with Eur. Ph. monograph “Ginkgo dry extract refined and quantified” current edition.

DMF, in compliance with international standard

Cannabis Therapeutic Solutions

Cannabis
Cannabis Therapeutic Solutions

Phytocannabinoids for pharmaceutical purposes

Every day, we develop and produce the finest cannabis and CBD extracts complying with the highest industry standards.

There are a large number of ongoing clinical and preclinical studies focusing on CANNABIS and CANNABINOIDS. CANNABIS and its derivatives has a multi-levels role in the organism, indicating the potential extent of a complex therapeutic scenario and representing an exciting target for disease management and health promotion.